Orphan Drugs market through 2022–2032, the market is projected to develop at a 4.6% CAGR. The market for orphan pharmaceuticals was estimated to be worth US$ 165.4 billion in 2021 and is expected to reach US$ 267.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.6%. Navigate Future Trends With a …